Skip to main content
x

Our Passionate Pursuit to Make a Difference Begins with Our Pipeline

Over the past 10 years, Neurelis has researched diligently to develop a pipeline of products with the potential to dramatically alter how patients challenged with epilepsy or acute anxiety episodes are treated.

Current areas of focus

VALTOCO™ (diazepam nasal spray)

An investigational product candidate being developed as an on-hand rescue treatment for intermittent use to control bouts of increased seizure activity.

LEARN MORE

NRL-2

A drug candidate being developed as on-hand rescue treatment for intermittent use to control acute anxiety episodes or panic attacks.

LEARN MORE

NRL-3

A drug candidate being developed as a non-invasive acute therapy to stop seizures that have progressed to status epilepticus.

LEARN MORE